BiotechTubeBiotechTube
Home/Idorsia/Alberto Gimona
AG

Alberto Gimona

Executive Committee Member

Idorsia

Therapeutic Areas

CNSCardiovascularImmunological DisordersOrphan Diseases

Idorsia Pipeline

DrugIndicationPhase
QUVIVIQ (daridorexant)InsomniaApproved/Commercial
TRYVIO/JERAYGO (aprocitentan)Resistant HypertensionApproved/Commercial
CenerimodSystemic Lupus Erythematosus (SLE)Phase 3
SelatogrelAcute Myocardial Infarction (AMI)Phase 3
Daridorexant (for PTSD)Post-Traumatic Stress DisorderClinical Study

Leadership Team at Idorsia

JC
Jean-Paul Clozel
Chairman of the Board and Interim CEO
AG
Arno Groenewoud
Executive Vice President, Chief Financial Officer
MC
Martine Clozel
Executive Vice President, Chief Scientific Officer & Head of Research
JG
Julien Gander
Chief Legal & Corporate Development Officer
BL
Benjamin Limal
President of EUCAN region
View full Idorsia profile